Christoph Klade is biochemist and immunologist with over 25 years of professional experience in the pharmaceutical industry in different companies. He has been active in discovery & preclinical research, pharmaceutical & clinical development, project management, quality management and regulatory affairs and leading teams in diverse therapeutic areas (haemato-oncology, cardio-pulmonology, psychiatry-neurology, gastroenterology, infectious diseases), different cultures (US, UK/Scotland, Austria/Germany) and varying organizational set-ups (mid to big pharma, start-up to mature biotech). He has achieved regulatory approval of three novel drugs and contributed to over 100 peer-reviewed papers, reviews, abstracts, book-chapters and patent applications. Additionally, he is lecturing at the University of Vienna.